The value of lactate dehydrogenase serum levels as a prognostic and predictive factor for advanced pancreatic cancer patients receiving sorafenib.

Faloppi, Luca

The value of lactate dehydrogenase serum levels as a prognostic and predictive factor for advanced pancreatic cancer patients receiving sorafenib. [electronic resource] - Oncotarget Oct 2015 - 35087-94 p. digital

Publication Type: Clinical Trial, Phase II; Journal Article; Randomized Controlled Trial

1949-2553

10.18632/oncotarget.5197 doi


Adult
Aged
Aged, 80 and over
Antineoplastic Agents--therapeutic use
Biomarkers, Tumor--blood
Disease-Free Survival
Female
Humans
Kaplan-Meier Estimate
L-Lactate Dehydrogenase--blood
Male
Middle Aged
Niacinamide--analogs & derivatives
Pancreatic Neoplasms--blood
Phenylurea Compounds--therapeutic use
Prognosis
Sorafenib